B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression

Published:2011-09 Issue:3 Volume:186 Page:1093-1099
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Yuan Hexing¹,Wei Xuedong¹,Zhang Guangbo²,Li Chen¹,Zhang Xueguang³,Hou Jianquan⁴

Affiliation:

1. Department of Urology, Soochow University, Suzhou, People's Republic of China

2. Clinical Immunology Laboratory, Soochow University, Suzhou, People's Republic of China

3. Institute of Medical Biotechnology, Soochow University, Suzhou, People's Republic of China

4. First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance;Berglund;J Urol,2008

2. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy;Roth;Cancer Res,2007

3. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome;Zang;Proc Natl Acad Sci USA,2007

4. Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer;Parker;Int J Radiat Oncol Biol Phys,2011

5. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production;Chapoval;Nat Immunol,2001

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration;International Immunopharmacology;2024-05

2. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3;Vaccines;2024-01-05

3. Alternative immune checkpoints in immunoregulatory profile of cancer stem cells;Heliyon;2023-12

4. A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC;OncoImmunology;2023-11-27

5. Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models;Journal of Clinical Investigation;2023-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3